Drug Pipeline

Cytokine-Induced Memory-like Natural Killer Cells Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06138587 Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia Recruiting
NCT06321484 Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in… Platinum-resistant Ovarian Cancer Recruiting
NCT06152809 CIML NK Cells With Venetoclax for AML Acute Myeloid Leukemia Recruiting
NCT07011004 A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute… Acute Myeloid Leukemia Refractory Recruiting
Sponsors Running Cytokine-Induced Memory-like Natural Killer Cells Trials
Dana-Farber Cancer Institute (3) Memorial Sloan Kettering Cancer Center (1)
Disease Areas
Leukemia (3) Acute Myeloid Leukemia (AML) (3) Myelodysplastic Syndromes (MDS) (1) Myelofibrosis (1) Ovarian Cancer (1)
Get alerts when Cytokine-Induced Memory-like Natural Killer Cells trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free